Hypertension

Two tests better than one for diagnosing diabetes in hypertensives

Published in Obesity and Diabetes Week, May 12th, 2003

A stepwise combination test to screen for diabetes in hypertensive patients identified all diabetics and was considerably less expensive than the "gold standard" oral glucose tolerance test, researchers report.

At the University of Vienna, Austria, researchers pitted the stepwise combination fasting plasma (blood) glucose and glycosylated hemoglobin for diabetes screening in hypertensive patients against the "gold standard" oral glucose tolerance test. Their findings were published in the American Journal of Hypertension.

"Diabetes in patients with high blood pressure is a highly dangerous combination," said Michael A. Weber, MD, an editor of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week

Source: Obesity and Diabetes Week (2003-05-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry